
Endo, Inc. Finalizes $105M Sale of International Pharmaceuticals Business
MALVERN, PA — Endo, Inc. (OTCQX: NDOI) announced it has completed the sale of its International Pharmaceuticals business, primarily operated through Canada-based Paladin Pharma Inc., to Knight Therapeutics Inc.
Endo, Inc. Finalizes $105M Sale of International Pharmaceuticals Business Read More